▶Ben Lamm asserts that Colossal has achieved unprecedented technological milestones in multiplex gene editing, claiming the ability to make over 50 edits at once and being the first to insert ancient DNA into a living species with 100% efficiency.Apr 2026

▶Lamm presents Colossal as having a robust and diversified business strategy, evidenced by raising over $485 million across the company and its foundation, spinning out three separate companies, and having investors that include the U.S. intelligence community.Apr 2026

▶Lamm's claims indicate Colossal is actively applying its technology to both high-profile de-extinction projects (mammoth, dire wolf) and immediate, critical conservation efforts, such as cloning the endangered red wolf.Apr 2026

▶Lamm consistently links the scientific work of de-extinction to a tangible, large-scale economic model based on ecosystem restoration, certified nature credits, and ecotourism, citing multi-billion dollar market potential.

▶Lamm's projection that Colossal's business model could generate 'billions of dollars in ARR' from certified nature credits and ecotourism is highly speculative, as it relies on the maturation of a nascent biodiversity market.

▶The claim that protecting forest elephants adds over $500 billion in value to the African economy, while attributed to peer-reviewed papers, represents a complex economic model whose assumptions and calculations could be subject to significant debate.Apr 2026

▶Lamm's discussion of developing a 'universal egg' and artificial wombs points to monumental scientific and ethical challenges that are presented as engineering problems, potentially understating the profound societal and regulatory hurdles.

▶The assertion that Colossal has created functional 'dire wolf proxies' with just 20 SNP edits is a significant claim, as the functional and behavioral similarity of these animals to ancient dire wolves would be difficult to prove and likely debated by paleontologists and geneticists.Apr 2026